We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BD DIAGNOSTIC SYSTEMS

BD Diagnostics manufactures and markets medical supplies and devices and diagnostic systems that include cellular ana... read more Featured Products: More products

Download Mobile App




Different Methods Compared for Species Identification of Enterococcus

By LabMedica International staff writers
Posted on 18 May 2020
Print article
Image: The BD Phoenix M50 Automated Microbiology System provides clinicians with accurate and timely identification and susceptibility results to help guide their therapy and patient management decisions (Photo courtesy of Becton‐Dickinson).
Image: The BD Phoenix M50 Automated Microbiology System provides clinicians with accurate and timely identification and susceptibility results to help guide their therapy and patient management decisions (Photo courtesy of Becton‐Dickinson).
Biochemical test‐based methodologies are still used in some laboratories for the identification of bacterial isolates, mainly because of the need for the performance of drug susceptibility tests. However, these systems are unable to distinguish some species, especially among Gram‐positive bacteria.

Matrix‐assisted laser desorption ionization time‐of‐flight mass spectrometry (MALDI‐TOF MS) is an efficient method used in clinical microbiology laboratories for the identification of clinically relevant microorganisms. Microorganisms can be identified using a reference database in a turnaround time of minutes, which is essential when rapid results are needed.

Medical Scientists at the Universidad Autónoma de Nuevo León (Monterrey, Mexico) evaluated the performance of two commercial MALDI‐TOF MS systems and three biochemical‐based systems and compared them to whole genome sequencing (WGS) as the gold standard for identifying isolates of vancomycin‐resistant enterococci (VRE). A total of 87 VRE clinical isolates recovered from urine (33%), soft tissue (24%), blood (16%), and other specimens (27%) were identified by the systems.

For both MALDI‐TOF instruments, the direct method was used for identification. The mass spectrometers were the Microflex system with Biotyper software 3.1 (Biotyper; Bruker Daltonics, Bremen, Germany) and the Vitek MS system (bioMérieux, Marcy l'Etoile, France). The biochemical‐based systems included the bioMérieux Vitek 2, Phoenix (Becton‐Dickinson, Franklin Lakes, NJ, USA), and MicroScan WalkAway (Siemens Healthcare Diagnostics, Munich, Germany) systems. Paired‐end sequencing runs were performed on an Illumina MiSeq instrument (Illumina, San Diego, CA, USA).

The scientists reported that among the 87 VRE, 71 and 16 were identified as Enterococcus faecium and Enterococcus faecalis by WGS. All 71 E. faecium were correctly identified by both mass spectrometers, as well as the Vitek 2 and Phoenix instruments. However, only 51 E. faecium isolates were correctly identified by the MicroScan system. The most frequent misidentification was Enterococcus casseliflavus (n = 20). For vancomycin‐resistant E. faecium, the Microflex Biotyper system had the highest sensitivity (85.54%), and all instruments (except for the MicroScan) had a 100% specificity and positive predictive value (PPV). Up to 87% of E. faecalis isolates were misidentified by VITEK MS and VITEK2, 81% by MicroScan and Phoenix, and 75% by Bruker biotyper. The NPV was lower than 38% for all devices. The instrument with the highest accuracy was the Bruker Biotyper system (86.21%).

The authors concluded that as the coverage of type strain‐genome sequence database continues to grow and the cost of DNA sequencing continues to decrease, genome‐based identification can be a useful tool for diagnostic laboratories, with its superior accuracy even over MALDI‐TOF and database‐driven operations. The study was published on May 1, 2020 in the Journal of Clinical Laboratory Analysis.



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.